The clinical diagnosis of pulmonary thromboembolic disease can be difficult and all the laboratory aids have disadvantages. A comparison of the relative values of these aids is timely.
At present a lung scan or pulmonary angiography are the most specific diagnostic procedures.
The perfusion lung scan is usually difficult to interpret in patients with chronic cardiopulmonary disease; it is not possible to obtain a pulmonary angiogram in every case of suspected thromboembolic pulmonary disease because of cardiorespiratory distress.
The alveolo-arterial gradient of Pco2 was suggested 15 years ago as a simple test for pulmonary embolism (Severinghaus and Stupfel, 1957 ;  Robin, Julian, Travis and Crump, 1959) but this is still not used in daily practice.
In the present paper, the results obtained by this last method are compared with those of the lung scan. 
METHODS
The alveolo-arterial gradient of carbon dioxide pressure (Pco2) is the difference between Paco2 and PACO.).
The Paco2 of blood drawn from the brachial artery after local anaesthesia was determined by the Astrup apparatus. When arterial blood had been taken, PACO, was measured with the Godart capnograph (Van Weerden, 1961) . The principle of this apparatus is the absorption of infrared rays by CO. Mean PACO, was calculated from each available plateau during blood withdrawal.
Arterial Pco2 can be measured accurately but the measurement of alveolar Pco, is more difficult as it depends on the accuracy of the infrared analyser and on a relatively normal distribution of ventilation in the lung. The latter problem was overcome by discarding a significant number of observations in which a plateau was not clearly seen. Figure 1 shows an example of an acceptable capnograph tracing (in which alveolar Pco, in the expired air reaches a plateau from which PACO. can be measured) and of a discarded one (in which no alveolar plateau is available). It is very important to measure PACO, from the alveolar plateau of the CO, concentration of the expired air curve rather than from the end-tidal 306
Pco2. In cases of hyperpnoea, or when ventilation distribution is abnormal, no alveolar plateau is available. Therefore, whenever possible, it is useful to carry out a forced expiration at the end of the test in order to detect possible abnormalities of ventilation distribution. Tulou (1966) demonstrated that if the difference between Pco2 during normal expiration and forced expiration is higher than 7 mmHg there is an abnormal ventilatory distribution. When respiration is very slow, PACO2 must be measured from the beginning of the alveolar plateau. Reichel (1960) demonstrated that PACO2 at the end of a long expiration might be higher than Paco2.
The accuracy of the infrared analyser is checked regularly (at least once a month) by means of CO2 tubes with precisely known concentration.
The alveolo-arterial gradient of CO2 becomes abnormal when the physiological dead space increases because of well-ventilated but unperfused alveoli. When this occurs, the unperfused alveoli no longer release CO2 into the expired air; therefore the C02 concentration of the expired air is much lower than that of arterial blood. The gradient is abnormal when it is greater than 5 mmHg (Lacoste, Tufik-Simao, Nikly, and Saunier, 1960) .
The percentage of well-ventilated but unperfused alveoli is derived from the formula of Severinghaus, Stupfel, and Bradley (1957) :
The percentage of ventilated but unperfused alveoli was considered abnormal whenever it exceeded 15%,'.
At the beginning of this study, the lung scan was done by intravenous injection of iodine-131 (311) macroaggregated albumin and later by intravenous injection of technetium-99m (e9mTc) albumin microspheres.
Only anterior views of the scans were quantitatively studied; the defects were estimated by planimetry according to the method of Tow and Wagner (1967) and recorded as percentages of the whole pulmonary precapillary bed. Defects corresponding to a radiological opacity, such as condensations and pleural fluid, were subtracted from the total vascular defect; therefore the defects due to pulmonary infarcts were eliminated.
A defect less than 5% of total pulmonary perfusion was considered as non-pathological because of the mean age of the studied patients, which exceeded 62 years.
Statistical evaluations of the differences between the groups of subjects were carried out by variance analysis after angular transformation of the original percentage data in order to obtain homogeneous variances and normal distributions (Snedecor, 1956 ).
MATERIAL
Our study was done on 312 patients divided into five groups ( ean defect of of the last three groups there was no significant n was 161 % difference. lifferent from In the group of patients with possible thrombo-,ed thrombo-embolic disease 53 scans were done; the mean also from the circulatory defect was 9-1% (range 0-36); in 33 ients (sum of cases (63%) the scan was abnormal.
In 27 cases The group of patients with non-embolic pulmonary diseases included 47 scans. The mean fects of each circulatory defect was 8-1% (range 0-50); in 21 cases (45 %) perfusion was abnormal.
In the group of patients with miscellaneous * a Proved cardiac diseases 12 scans were done; the mean o -Probable circulatory defect was 10-7% (range 0-50) and in nine cases (75%) scintigraphic abnormalities were * evident.
Figures 3 and 4 demonstrate the lack of relation between the importance of the vascular defect (evaluated by the alveolo-arterial gradient of CO2 measurement or by the scan) and the duration of the disease from the first symptoms to the date of the measurement of the alveolo-arterial gradient of CO2 or of the scan. (Szucs et al., 1971) , is not a sufficiently selective test.
The clinical advantage of the measurement of the alveolo-arterial gradient of Pco, for the diagnosis of thromboembolic disease was first emphasized by Robin et al. (1959 Robin et al. ( , 1960 . Previously, in animal experiments Severinghaus and Stupfel (1957) had provoked large alveolo-arterial gradients by artificial emboli. These studies were confirmed by other authors Levy et al., 1965; Stein, Fork- ner, Robin, and Wessler, 1961 ;  Thomas et al., 1964) ; there is a clear parallelism between the importance of the gradient and the area of the obliterated vascular bed . In 1968, temporary pulmonary artery occlusion in man with an intraluminal balloon during cardiac catheterization showed similar results (Janota, Widimsky, Hurych, and Stanek, 1968) . Except for the work of MacKeen, Landrigan, and Dickson (1961) there has been no clinical study in which the alveolo-arterial gradient of Pco, has been measured in a large series of patients. However, some authors confirmed the clinical value of the alveolo-arterial gradient of Pco2 for the diagnosis of thromboembolic disease (Llamas and Swenson, 1965; Mostyn and Luft, 1967; Nutter and Massumi, 1966; Robin et al., 1959 Robin et al., , 1960 . Other authors (Jones and Goodwin, 1965; Nikodymova, Daum, Stiksa, and Widimsky, 1968 ) measured the alveolo-arterial gradient of Pco2 in order to study the late sequels of pulmonary embolism; the mean alveolo-arterial gradient of Pco2 was not clearly abnormal but was, however, a little higher than in normal subjects. Nadel, Gold, and Burgess (1968) studied eight patients with dyspnoea due to obliteration of peripheral branches of the pulmonary artery; six of the eight cases had an abnormal alveolo-arterial gradient of Pco0.
In our series of 103 cases (groups I and II) the diagnosis of thromboembolic disease was confirmed in 59% of the cases of proved thromboembolic disease by the alveolo-arterial gradient measurement with calculation of the percentage of the ventilated but unperfused alveoli. In nearly 48% (49) of the cases (Table IV) this test did not (Cahill, Attinger, and Byrne, 1961; Nadel, Colebatch, and Olsen, 1964; Severinghaus et al., 1961 ; Stein et al., 1961; Thomas et al., 1964; Tisi, Wolfe, Fallat, and Nadel, 1970) and in man (Gurewich, Thomas, Stein, and Wessler, 1963; Swenson, Finley, and Guzman, 1961 .
To correct this underestimation of the vascular defect. Robin et al. (1960) The test was positive in nearly 60% of the cases of proved thromboembolic disease. This percentage is a little lower than in the studies of Robin et al. (1959 Robin et al. ( , 1960 in which 11 out of 16 cases (69%) had an abnormal percentage of ventilated but unperfused alveoli. It is much lower than in the study of MacKeen et al. (1961) in which 16 out of 17 cases (94 %) had an abnormal alveoloarterial gradient of Pco2. Nutter and Massumi (1966) found a higher physiological dead space in 15 out of 20 cases (75%); they measured PACO, from a sample of expired air that was considered equivalent to alveolar air; this may overestimate the alveolar dead space in thromboembolic disease and in normal subjects.
On the other hand, there were only 12 cases out of 105 (11 %) in which the scan did not confirm the clinical diagnosis of thromboembolic disease (Table IV) . In eight of these cases the scintigraphic defect corresponded to pulmonary infarcts demonstrated by radiological opacities and were therefore not retained. In three more cases the emboli were presumably too small to be demonstrated by an investigation of such large scope. Finally, in the last case, the examination was done very late, during treatment, when restoration of the pulmonary circulation was nearly complete. Although they are based on a different approach to the problem of pulmonary perfusion both methods provide significantly correlated results. There is a significant correlation between the vascular defects either measured by lung scan or calculated from the alveolo-arterial gradient of Pco2 but these methods do not provide identical results (Fig. 5) .
This relationship shows that the scan has greater sensibility for the smaller emboli; the normal alveolo-arterial gradient in such cases is probably explained by bronchoconstriction and hypoventilation occurring in pulmonary embolism (Cahill et al., 1961; Gurewich et al., 1963; Nadel et al., 1964; Severinghaus et al., 1961 ; Stein et al., 1961; Thomas et al., 1964; Tisi et al., 1970) . On the other hand, the discrepancy between both estimations of vascular defect could be due to the fact that only the anterior views of the scan were retained for planimetry. The alveoloarterial gradient of CO2 can be overestimated when the alveolar plateau is not correctly evaluated although all capnograms without evident plateaus were eliminated. In chronic cardiopulmonary disease the pulmonary scan can lead to overestimation of vascular defects from thromboembolic disease. The presence of pulmonary infarcts would not explain these results: they were not retained for scintigraphic planimetry, and as they cause a ventilatory as well as a circulatory defect they do not impair the alveolo-arterial gradient of Pco0.
We found that the delay between the beginning of the symptoms and the investigation (measurement of the alveolo-arterial gradient of Pco. or scan) is not critical for the diagnosis of thromboembolic disease. Indeed, without any treatment there seems to be no improvement in perfusion within the first 30 to 50 days, probably because of further embolism and the time needed for recanalization. Therefore these investigations remain useful for the diagnosis of thromboembolic disease even after several weeks.
For comparison, alveolo-arterial gradient of Pco2 and lung scan were studied in non-embolic diseases (groups IV and V) ( Table IV) . In 15 cases out of 66 (22-5%) there was an abnormal percentage of ventilated but unperfused alveoli. These included five cases of chronic bronchitis, two cases of massive pleural effusion, and one case each of old tuberculosis, bronchial neoplasm, chronic mediastinitis, pleural thickening, uraemic lung, mitral regurgitation, myocardial infarct and cardiac failure. In some cases the excess of ventilated but unperfused alveoli was due to an abnormal ventilatory distribution with a capnographic plateau which did not correspond to true alveolar air; in other cases vascular obliteration was greater than the ventilatory defect. In 30 cases out of 59 (51 %) the lung scan was pathological. In chronic pulmonary diseases such as emphysema, silicosis, and old tuberculosis, ventilatory abnormalities lead to vascular defects; in bronchial neoplasms there may be vascular compression or local thrombosis. In cardiac failure without clinical pulmonary symptoms, the lung scan is always difficult to interpret and may lead to a false diagnosis of thromboembolic disease when the defects are actually due to chronic pulmonary hypertension. Pulmonary angiography is considered to be the most specific procedure for the diagnosis of thromboembolic disease. Nevertheless it should be stressed that it cannot reveal emboli in thirdorder vessels (Dalen et al., 1966; Dalen, 1970) .
CONCLUSION
The measurement of the alveolo-arterial gradient of Pco. and of the percentage of the ventilated but unperfused alveoli is a simple and rapid test for the diagnosis of thromboembolic disease. Nevertheless the lung scan is more accurate, especially for small emboli. The percentage of ventilated but unperfused alveoli was abnormally high in 59 % of our cases of proved thromboembolic diseases. As for the lung scan, this measurement is useful chiefly for patients without other cardiopulmonary disorder.
In both methods, underestimation or overestimation of vascular defects may lead to erroneous results. They must be interpreted together with the clinical data.
If these procedures are used first, pulmonary angiography could be reserved for those cases in which the diagnosis remains in doubt and for those in which surgical or fibrinolytic treatment is being considered. We are very grateful to Mrs. Brassienne and to Miss De Bruyn for technical assistance.
